Disproportional response: a small company's current business is visibly outgrowing its own size
The model's full reasoning — Q3 2022 call → NOWe need to determine if management conveys that the business is currently outgrowing the company's size, with disproportionate scale relative to its smallness. Look for statements about current demand, wins, or commitments that are large relative to the company's current size. In the transcript, Jag mentions: "we have had many project wins with existing and new customers, which will provide a buffer to potential market softness." Also, "our new business pipeline remains strong." But these are about future wins, not necessarily current scale. However, there is a specific statement: "We recently won a large family of parts for an electric side-by-side that will make up the battery enclosure on the vehicle. Production of this side-by-side model will fully launch in 2023" - that's future. Also "we were awarded a high-value takeover project for a current ag customer" - that's a win, but not necessarily disproportionate. The key is whether management explicitly contrasts the size of the company with the scale of what's arriving. They mention "we have been able to win incremental business" and "opportunities for reshoring projects continue to grow." But no explicit statement like "this single contract is as large as our current revenue" or "we are small but the demand is huge." They do mention "we see the potential for significant growth over the next five years" but that's forward-looking. Also, they talk about "our new business pipeline remains strong" but that's not current. The question asks: "does management describe current activity, demand, or commitments arriving at a scale that is large relative to how small the company still is?" They mention "we have had many project wins" but not that these wins are disproportionately large relative to the company's size. They also mention "we have been able to quickly support urgent product needs" for a new customer, but again no disproportion. There is no explicit statement like "this one program will double our revenue" or "we are a small company but we are handling orders that would be huge for us." The company is a mid-sized contract manufacturer, and they report strong growth, but they don't convey that the current business is outgrowing their size in a disproportionate way. They talk about growth opportunities, but that's typical. Thus, answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
VNRX · Q1 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management explicitly describing the Heska deal (already signed and with $10M upfront received) as a long-term, multi-year commitment that will generate ongoing kit/component revenue "significantly greater" than the $28M milestones, with "millions of tests" expected each year — all while repeatedly noting the company is "not a big company" and that this is "the beginning of our commercial journey" after 12 years of R&D. They contrast this with their tiny current revenue ($114k) and cash position, framing the new activity as disproportionately large relative to their size.
TMCI · Q2 2022 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES Management explicitly describes the business as outgrowing its current setup in present-tense terms: they are “once again in the process of relocating to a larger headquarters facility” to meet “increased requirements” for training, R&D, warehousing, and infrastructure; the direct sales force has grown 52% to 123 quota-carrying reps and is already trending above the year-end 70% direct mix goal; surgeon penetration has reached 20% of the estimated 10,000 U.S. foot-and-ankle surgeons while procedure penetration is 4.6% of the 450,000 annual U.S.
KOPN · Q4 2023 → YESThe question is: Does management convey that the business the company is doing RIGHT NOW is visibly outgrowing the company's own current size and setup? That current activity, demand, or commitments a...YES The transcript shows management describing current activity (a $55 million backlog, a $20.5 million new order, follow-on orders, and tripled weapon-site volume expected in 2024) as large relative to the company’s still-small size and setup. They explicitly note the backlog is a “record level 10 years,” that they had to extend the holiday shutdown and retool the plant for a “significant increase in production,” and that they are “buying to that level of volume today” while remaining conservative on guidance.